๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kura Oncology, Inc. (KURA)
NASDAQ: KURA ยท Real-Time Price ยท USD
7.35
+0.01 (0.14%)
At close: Nov 19, 2026, 4:00 PM EST
7.41
+0.06 (0.82%)
After-hours: Nov 19, 2026, 7:56 PM EST

Kura Oncology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
79.3167.4853.88---
Revenue Growth
-23.76%25.24%----
Gross Profit
-180.06-183.65-116.08-115.24-92.81-
Operating Income
-312.75-303.63-193.2-165.8-139.87-131.26
Net Income
-292.87-278.67-173.98-152.63-135.84-130.47
Earnings Per Share
-3.30-3.18-2.02-2.08-2.03-1.97
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
492.1667.24727.4423.96437.99517.96
Total Debt
25.8320.4616.5917.214.026.88
Net Cash (Debt)
466.27646.78710.8406.76423.96511.09
Net Cash Growth
-12.06%-9.01%74.75%-4.06%-17.05%-17.35%
Net Cash Per Share
5.257.388.255.556.337.70

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-85.57-64.06134.32-124.82-110.06-104.55
Capital Expenditures
-3.55-6.64-0.47-0.17-0.63-1.15
Free Cash Flow
-89.12-70.7133.85-124.99-110.69-105.7
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-227.02%-272.14%-215.44%---
Operating Margin
-394.32%-449.94%-358.54%---
Pretax Margin
-369.15%-412.51%-319.15%---
Profit Margin
-369.26%-412.95%-322.89%---
FCF Margin
-112.37%-104.76%248.40%---

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--5.06---
PS Ratio
8.5113.4012.57---